The relationship between blood leptin level and bone density is specific to ethnicity and menopausal status.
Leptin, the obesity hormone, has been linked to bone mineralization and tumorigenesis. In addition, both bone mineral density (BMD) and postmenopausal breast cancer are associated with obesity, but the interrelationships between obesity, leptin, BMD, and breast cancer are not yet clear. In particular, there is little published research comparing white and black women in terms of these variables. We obtained blood specimens for leptin analysis from a group of 320 breast cancer patients and controls with an ethnic composition of 49% white women and 51% black women. Distal and proximal radial BMD (DBMD and PBMD) were measured by dual-energy X-ray absorptiometry, and age- and ethnicity-specific standardized scores (Z-scores) were calculated for bone density. Blood leptin levels were determined by radioimmunoassay. Blood leptin level was not linked to breast cancer risk. Leptin levels were significantly higher in black women than in white women and were also significantly higher in obese and overweight women than in normal-weight women. Black women weighed more and had a higher body mass index (BMI) than white women. After controlling for BMI, leptin was correlated with DBMD ( r = .17; P < .05) and PBMD ( r = .21; P < .05) in whites, but not in blacks. Leptin was also correlated with both distal and proximal Z-scores in postmenopausal women ( r = .14 and .13; P < .05). Thus leptin may be a predictor for BMD in a population that is prone to have a low BMD, and this relationship is independent of the effect of body weight on leptin levels. Our results suggest that ethnicity and menopausal status should be considered when comparing results from different studies.
Jen
K-L Catherine
KL
Department of Nutrition and Food Science, Wayne State University, Detroit, MI 48202, USA. cjen@sun.science.wayne.edu
Buison
Anne
A
Darga
Linda
L
Nelson
Dorothy
D
D044383:Black People; D015992:Body Mass Index; D001835:Body Weight; D015519:Bone Density / Q000502:physiology*; D001943:Breast Neoplasms / Q000097:blood* / Q000208:ethnology; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D020738:Leptin / Q000097:blood*; D008593:Menopause / Q000097:blood / Q000502:physiology*; D008875:Middle Aged; D044465:White People
D020738:Leptin